Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study (Q44304694)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study |
scientific article |
Statements
1 reference
Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study (English)
1 reference
Chloe Orkin
1 reference
Francois Raffi
1 reference
Anita Rachlis
1 reference
Hans-Jürgen Stellbrink
1 reference
W David Hardy
1 reference
Carlo Torti
1 reference
Mark Bloch
1 reference
Daniel Podzamczer
1 reference
Vadim Pokrovsky
1 reference
Steve Almond
1 reference
David Margolis
1 reference
Clare Brennan
1 reference
Sherene Min
1 reference
SPRING-2 Study Group
1 reference
8 January 2013
1 reference
1 reference
381
1 reference
9868
1 reference
735-743
1 reference
Identifiers
1 reference
1 reference